{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:44:23Z","timestamp":1794347063497,"version":"4.9.0"},"publisher-location":"Chichester, UK","reference-count":70,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd005590.pub2","type":"reference-entry","created":{"date-parts":[[2007,7,3]],"date-time":"2007-07-03T10:37:15Z","timestamp":1183459035000},"source":"Crossref","is-referenced-by-count":73,"title":["Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients"],"prefix":"10.1002","author":[{"given":"Hefziba","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mical","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Leibovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,7,18]]},"reference":[{"key":"10.1002\/14651858.CD005590.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jac\/26.suppl_D.137","article-title":"Infection prophylaxis in neutropenic patients with acute leukaemia--a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole\/colistin","volume":"26 Suppl D","author":"Arning","year":"1990","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"8","key":"10.1002\/14651858.CD005590.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/sj.bmt.1702004","article-title":"A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim\/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation","volume":"24","author":"Colby","year":"1999","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD005590.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0002-9343(90)90337-D","article-title":"A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis","volume":"89","author":"Fox","year":"1990","journal-title":"American Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005590.pub2-BIB4|cit4","first-page":"11","article-title":"A prospective, randomised, double-blind study of thrimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation. side effects of trimethoprim-sulfamethoxazole, interaction with cyclosporine","volume":"119","author":"Maki","year":"1992","journal-title":"Journal of Laboratory Clinical Medicine"},{"issue":"3","key":"10.1002\/14651858.CD005590.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00006454-198505000-00012","article-title":"Use of trimethoprim-sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemia","volume":"4","author":"Goorin","year":"1985","journal-title":"Pediatric Infectious Disease"},{"key":"10.1002\/14651858.CD005590.pub2-BIB6|cit6","unstructured":"Hibberd PL Tolkoff-Rubin NE Doran M Delvecchio A Cosimi AB Delmonico FL Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial Online Journal of Current Clinical Trials 1992"},{"issue":"26","key":"10.1002\/14651858.CD005590.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM197712292972602","article-title":"Successful chemoprophylaxis for Pneumocystis carinii pneumonitis","volume":"297","author":"Hughes","year":"1977","journal-title":"New England Journal of Medicine"},{"issue":"26","key":"10.1002\/14651858.CD005590.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM198706253162604","article-title":"Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis","volume":"316","author":"Hughes","year":"1987","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD005590.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/AAC.34.2.215","article-title":"Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy","volume":"34","author":"Liang","year":"1990","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD005590.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00007890-199308000-00021","article-title":"Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim sulfamethoxazole","volume":"56","author":"Olsen","year":"1993","journal-title":"Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD005590.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1086\/520432","article-title":"Randomized trial of weekly sulfadoxine\/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation","volume":"29","author":"Torre-Cisneros","year":"1999","journal-title":"Clinical Infectious Disease"},{"issue":"1","key":"10.1002\/14651858.CD005590.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/1097-0142(19870101)59:1<19::AID-CNCR2820590108>3.0.CO;2-B","article-title":"Effect of trimethoprim\/sulfamethoxazole prophylaxis on outcome of childhood lymphocytic leukemia. A Pediatric Oncology Group Study","volume":"59","author":"Eys","year":"1987","journal-title":"Cancer"},{"issue":"6","key":"10.1002\/14651858.CD005590.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/clinids\/22.6.920","article-title":"Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients","volume":"22","author":"Arend","year":"1996","journal-title":"Clinical Infectious Disease"},{"issue":"1","key":"10.1002\/14651858.CD005590.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/08880019209006394","article-title":"Prospective randomized comparison of toxicity of two prophylactic regimens of cotrimoxazole in leukemic children","volume":"9","author":"Arico","year":"1992","journal-title":"Pediatric Hematology and Oncology"},{"issue":"2","key":"10.1002\/14651858.CD005590.pub2-BIB15|cit15","first-page":"130","article-title":"Systemic Pneumocystis carinii pneumonia prophylaxis with dapsone and pyrimethamine fails to protect against extrapulmonary pneumocystosis","volume":"69","author":"Carlin","year":"1993","journal-title":"Genitourinary Medicine"},{"issue":"8","key":"10.1002\/14651858.CD005590.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/1529-0131(200008)43:8<1841::AID-ANR21>3.0.CO;2-Q","article-title":"Cost-effectiveness of prophylaxis against Pneumocystis carinii pneumonia in patients with Wegner's granulomatosis undergoing immunosuppressive therapy","volume":"43","author":"Chung","year":"2000","journal-title":"Arthritis and Rheumatism"},{"issue":"8827","key":"10.1002\/14651858.CD005590.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0140-6736(92)93120-C","article-title":"Co-trimoxazole versus dapsone-pyrimethamine for prevention of Pneumocystis carinii pneumonia","volume":"340","author":"Coker","year":"1992","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD005590.pub2-BIB18|cit18","first-page":"81","article-title":"Effectiveness of low-dose cotrimoxazole prophylaxis against Pneumocystis carinii pneumonia after renal and\/or pancreas transplantation","volume":"5","author":"Elinder","year":"1992","journal-title":"Transplant International"},{"issue":"3","key":"10.1002\/14651858.CD005590.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1378\/chest.104.3.743","article-title":"A randomized comparison of once-monthly or twice-monthly high-dose aerosolized pentamidine prophylaxis","volume":"104","author":"Golden","year":"1993","journal-title":"Chest"},{"key":"10.1002\/14651858.CD005590.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"A38","DOI":"10.1055\/s-2001-17501","article-title":"[Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer]","volume":"213 Suppl 1","author":"Groll","year":"2001","journal-title":"Klinische Pediatrie"},{"key":"10.1002\/14651858.CD005590.pub2-BIB21|cit21","series-title":"40th interscience conference on antimicrobial agents and chemotherapy","article-title":"Aerosolized pentamidine (APNT) compared to trimethoprim\/sulfamethoxazole (TMP\/SMX) for pneumocystis carinii pneumonia prophylaxis (PCP) following orthotopic liver transplantation","author":"Holt","year":"2000"},{"issue":"8","key":"10.1002\/14651858.CD005590.pub2-BIB22|cit22","first-page":"758","article-title":"Pneumocystis carinii pneumonia in infants after heart transplantation","volume":"15","author":"Janner","year":"1996","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD005590.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/1097-0142(19840115)53:2<329::AID-CNCR2820530226>3.0.CO;2-X","article-title":"Prophylaxis of fever and infection in adult cancer patients. A placebo-controlled trial of oral trimethoprim-sulfamethoxazole plus erythromycin","volume":"53","author":"Kramer","year":"1984","journal-title":"Cancer"},{"issue":"3","key":"10.1002\/14651858.CD005590.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/00007890-199203000-00019","article-title":"Trimethoprim-sulfamethoxazole prophylaxis for Pneumocystis carinii infections in heart-lung and lung transplantation--how effective and for how long?","volume":"53","author":"Kramer","year":"1992","journal-title":"Transplantation"},{"issue":"8750","key":"10.1002\/14651858.CD005590.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/0140-6736(91)92829-Q","article-title":"Low-dose co-trimoxazole, aerosolised pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia","volume":"337","author":"Mallolas","year":"1991","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005590.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/978-3-642-74643-7_94","article-title":"Prevention of infection in acute leukemia","volume":"33","author":"Maschmeyer","year":"1990","journal-title":"Haematology and Blood Transfusion"},{"issue":"1-2","key":"10.1002\/14651858.CD005590.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/10428199709109161","article-title":"Antimicrobial prophylaxis to prevent opportunistic infections in patients with chronic lymphocytic leukemia after allogeneic blood or marrow transplantation","volume":"26","author":"Mehta","year":"1997","journal-title":"Leukemia and Lymphoma"},{"issue":"8","key":"10.1002\/14651858.CD005590.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1053\/jlts.2001.26433","article-title":"Pneumocystis carinii pneumonia prophylaxis with atovaquone in trimethoprim-sulfamethoxazole-intolerant orthotopic liver transplant patients: a preliminary study","volume":"7","author":"Meyers","year":"2001","journal-title":"Liver Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD005590.pub2-BIB29|cit29","first-page":"1818","article-title":"[Infection prophylaxis in patients with hematological malignancies (I)--Successful prophylaxis of Pneumocystis carinii pneumonitis with sulfamethoxazole-trimethoprim]","volume":"31","author":"Moriuchi","year":"1990","journal-title":"Rinsho Ketsueki"},{"issue":"2","key":"10.1002\/14651858.CD005590.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.1994.12.2.258","article-title":"Aerosolized pentamidine for the prevention of Pneumocystis carinii pneumonia in children with cancer intolerant or allergic to trimethoprim\/sulfamethoxazole","volume":"12","author":"Mustafa","year":"1994","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD005590.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1399-3062.2003.00033.x","article-title":"Infectious complications in patients randomized to receive allogeneic bone marrow or peripheral blood transplantation","volume":"5","author":"Nucci","year":"2003","journal-title":"Transplant Infectious Disease"},{"issue":"11","key":"10.1002\/14651858.CD005590.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.11150\/kansenshogakuzasshi1970.73.1123","article-title":"Efficacy of sulfamethoxazole-trimethoprim administration in the prevention of Pneumocystis carinii pneumonia in patients with connective tissue disease","volume":"73","author":"Okada","year":"1999","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1002\/14651858.CD005590.pub2-BIB33|cit33","unstructured":"Pedagogos E Nicholls K Wilson J Waiker R Becker G Comparison of oral trimethoprim\/sulfamethoxazole (TMP-SMX) and inhaled pentamidine (P) for prevention of pneumocystis pneumonia (PCP) after renal transplantation The Transplantation Society of Australia and New Zealand 1994"},{"issue":"11","key":"10.1002\/14651858.CD005590.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/0277-5379(87)90449-4","article-title":"Prospective randomized comparison of two prophylactic regimens with trimethoprim-sulfamethoxazole in leukemic children: a two year study","volume":"23","author":"Rossi","year":"1987","journal-title":"European Journal of Cancer Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD005590.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00002281-199905000-00004","article-title":"Prevention of infectious complications in rheumatic disease patients: immunization, Pneumocystis carinii prophylaxis, and screening for latent infections","volume":"11","author":"Singer","year":"1999","journal-title":"Current Opinion in Rheumatology"},{"issue":"10","key":"10.1002\/14651858.CD005590.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/00002030-199210000-00017","article-title":"Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis: an open randomized prospective trial to assess efficacy and haematological toxicity","volume":"6","author":"Slavin","year":"1992","journal-title":"Aids"},{"issue":"6","key":"10.1002\/14651858.CD005590.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1086\/313509","article-title":"High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis","volume":"29","author":"Souza","year":"1999","journal-title":"Clinical Infectious Disease"},{"issue":"1","key":"10.1002\/14651858.CD005590.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199607043350103","article-title":"Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group","volume":"335","author":"Stegeman","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD005590.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/00007890-199611270-00026","article-title":"Effectiveness of daily low-dose cotrimoxazole prophylaxis for Pneumocystis carinii pneumonia in liver transplantation--an open clinical trial","volume":"62","author":"Torre-Cisneros","year":"1996","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD005590.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1083-8791(00)70050-4","article-title":"Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections","volume":"6","author":"Vasconcelles","year":"2000","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD005590.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1200\/JCO.1994.12.1.136","article-title":"Successful Pneumocystis carinii pneumonia prophylaxis using aerosolized pentamidine in children with acute leukemia","volume":"12","author":"Weinthal","year":"1994","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD005590.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.bjc.6602412","article-title":"An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital","volume":"92","author":"Worth","year":"2005","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD005590.pub2-BIB43|cit43","first-page":"193","article-title":"Treatment of Pneumocystis carinii pneumonia: current status of the regimens of pentamidine isethionate and pyrimethamine-sulfadiazine","volume":"43","author":"Young","year":"1976","journal-title":"National Cancer Institute Monograph"},{"key":"10.1002\/14651858.CD005590.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1093\/clinids\/9.Supplement_2.S177","article-title":"Use of trimethoprim-sulfamethoxazole singly and in combination with other antibiotics in immunocompromised patients","volume":"9 Suppl 2","author":"Young","year":"1987","journal-title":"Review of Infectious Disease"},{"key":"10.1002\/14651858.CD005590.pub2-BIB45|cit45","unstructured":"Alderson P Green S Higgins JPT (editors) Appendix 5b: Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. In: Alderson P, Green S, Higgins JPT (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 4.2.5 [updated May 2005]. The Cochrane Collaboration 2005. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD005590.pub2-BIB46|cit46","unstructured":"Alderson P Green S Higgins JPT (editors) Section 6.3: Selection bias. In Alderson P, Green S, Higgins JPT (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 4.2.5 [updated May 2005]. The Cochrane Collaboration, 2005. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD005590.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1034\/j.1399-3062.2001.003003128.x","article-title":"Infectious complications of lung transplantation","volume":"3","author":"Alexander","year":"2001","journal-title":"Transplant Infectious Diseases"},{"key":"10.1002\/14651858.CD005590.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1002\/art.11301","article-title":"Infections and anti-tumor necrosis factor alpha therapy","volume":"48","author":"Ellerin","year":"2003","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD005590.pub2-BIB49|cit49","unstructured":"FDA Safety update on TNF-alfa antagonists: infliximab and etanerecept. Food and Drug Administration, Center for Biologics Evaluation and Research 2001"},{"key":"10.1002\/14651858.CD005590.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jama.259.8.1185","article-title":"Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS","volume":"259","author":"Fischl","year":"1988","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD005590.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jama.279.2.130","article-title":"The cost-effectiveness of preventing AIDS-related opportunistic infections","volume":"279","author":"Freedberg","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD005590.pub2-BIB52|cit52","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003508","article-title":"Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV","author":"Grimwade","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005590.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/109629603322419607","article-title":"Fungal infections in solid organ transplant patients","volume":"4","author":"Hagerty","year":"2003","journal-title":"Surgical Infections"},{"key":"10.1002\/14651858.CD005590.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1086\/515658","article-title":"Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virus-infected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis","volume":"178","author":"Kaplan","year":"1998","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD005590.pub2-BIB55|cit55","first-page":"1","article-title":"Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America","volume":"51","author":"Kaplan","year":"2002","journal-title":"MMWR. Morbidity and mortality weekly report"},{"key":"10.1002\/14651858.CD005590.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1034\/j.1399-3062.4.s3.4.x","article-title":"Fungal infection in lung transplantation","volume":"4 Suppl 3","author":"Kubak","year":"2002","journal-title":"Transplant Infectious Diseases"},{"key":"10.1002\/14651858.CD005590.pub2-BIB57|cit57","first-page":"3080","article-title":"Pneumocystis species","volume-title":"In: Mandel, Douglas and Bennet's principles and practice of infectious diseases","volume":"2","author":"Walzer","year":"2004"},{"key":"10.1002\/14651858.CD005590.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1378\/chest.118.3.704","article-title":"Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states","volume":"118","author":"Mansharamani","year":"2000","journal-title":"Chest"},{"issue":"9128","key":"10.1002\/14651858.CD005590.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD005590.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.10.1.86","article-title":"Infections in solid-organ transplant recipients","volume":"10","author":"Patel","year":"1997","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1002\/14651858.CD005590.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2133.1999.03052.x","article-title":"Pneumocystis carinii pneumonia in patients receiving immunosuppressive drugs for dermatological diseases","volume":"141","author":"Raychaudhuri","year":"1999","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD005590.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/CMR.17.4.770-782.2004","article-title":"Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients","volume":"17","author":"Rodriguez","year":"2004","journal-title":"Clinical Microbiology Reviews"},{"issue":"5","key":"10.1002\/14651858.CD005590.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD005590.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"S416","DOI":"10.1093\/clinids\/17.Supplement_2.S416","article-title":"Pneumocystis carinii pneumonia in patients without AIDS","volume":"17","author":"Sepkowitz","year":"1993","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD005590.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome","volume":"34","author":"Sepkowitz","year":"2002","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD005590.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3201\/eid1010.040362","article-title":"Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia","volume":"10","author":"Stein","year":"2004","journal-title":"Emerging Infectious Diseases"},{"key":"10.1002\/14651858.CD005590.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3201\/eid0809.020096","article-title":"A new name (Pneumocystis jiroveci) for Pneumocystis from humans","volume":"8","author":"Stringer","year":"2002","journal-title":"Emerging Infectious Diseases"},{"key":"10.1002\/14651858.CD005590.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005590.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1086\/319340","article-title":"Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants","volume":"32","author":"Vargas","year":"2001","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD005590.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy","volume":"71","author":"Yale","year":"1996","journal-title":"Mayo Clinics Proceedings"}],"updated-by":[{"DOI":"10.1002\/14651858.cd005590.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD005590.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:51:17Z","timestamp":1628531477000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD005590.pub2"}},"subtitle":[],"editor":[{"given":"Hefziba","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,7,18]]},"references-count":70,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005590.pub2","relation":{},"subject":[],"published":{"date-parts":[[2007,7,18]]}}}